Melbourne Health
Clinical trials sponsored by Melbourne Health, explained in plain language.
-
New Two-Pronged attack aims to save insulin cells in kids with diabetes
Disease control CompletedThis study tested whether combining two immune-modifying treatments—abatacept (a weekly injection) and nasal insulin (a spray)—could help protect the pancreas's remaining insulin-producing cells in children and young adults recently diagnosed with type 1 diabetes. The goal was to…
Phase: PHASE2 • Sponsor: Melbourne Health • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
New drug tested in brain tumor patients before surgery
Disease control CompletedThis study tested a drug called AB-218 (Safusidenib) in patients with a specific genetic type of slow-growing brain tumor (IDH1 mutated low-grade glioma). The main goal was to see if it was practical to give the drug before planned surgery and to measure how much of the drug reac…
Phase: EARLY_PHASE1 • Sponsor: Melbourne Health • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC